Medicaid Provider SpendingClaims paid 2018–2024 · HHS public file
Home › CA › Torrance › NPI 1902844988
Hospital

Providence Health System Southern California

Providence Health System Southern California was paid $27.29M by Medicaid between Jan 2018 and Dec 2024, across 252 billing codes. Its largest line is 0450, Emergency room services — 15% of everything it billed.

33Billing provider infoPROVIDENCE HEALTH SYSTEM SOUTHERN CALIFORNIA
TORRANCE, CA 90503
33aNPI1902844988assigned 06/03/2006
28Total paid$27.29M
24GClaims1,011,657
24DCodes billed252
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers

Next to other General Acute Care Hospital providers in California

Rank by total paid#97 of 410
Median peer was paid$6.90M
This provider vs. median4.0×

Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.

Auditor's notes

Automated statistical signals. Not evidence of fraud — how these are computed.

Entity ProliferationAuthorized official ANDERSON, DONALD controls 20+ related entities in our dataset. Read more
Box 24A · Dates of service

Paid by month

$0$200K$400K$600K2018201920202021202220232024
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
YearClaimsPaid
2018207,505$4.20M
2019167,857$4.33M
2020124,125$2.83M
2021135,569$3.71M
2022122,071$4.41M
2023138,687$4.73M
2024incomplete115,843$3.10M
Box 24 · Service lines

What it billed for

CodeServiceShareClaimsBene. recordsPaid
0450 Emergency room services 15% 84,685 77,088 $4.07M
74177 Computed tomography, abdomen and pelvis; with contrast material 6.5% 8,952 8,550 $1.77M
87633 Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets 5.9% 7,220 7,080 $1.61M
70450 Computed tomography, head or brain; without contrast material 4.4% 9,872 9,475 $1.21M
96374 Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance 3.7% 23,632 22,175 $1.02M
93005 Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report 2.8% 34,040 31,690 $763K
99285 Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life 2.7% 3,444 3,235 $724K
80053 Comprehensive metabolic panel 2.4% 56,192 50,843 $658K
87635 Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe 2.4% 17,559 16,771 $646K
99281 Emergency department visit for the evaluation and management, self-limited or minor 2.1% 10,124 9,188 $581K
74176 Computed tomography, abdomen and pelvis; without contrast material 2.1% 4,391 4,202 $563K
80307 Drug test(s), presumptive, any number of drug classes; immunoassay 1.9% 11,439 9,749 $530K
240 more codes
96375 Therapeutic injection; each additional sequential IV push 1.7% 16,286 $475K
87798 Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism 1.7% 7,200 $474K
85025 Blood count; complete (CBC), automated, and automated differential WBC count 1.5% 59,199 $413K
96361 Intravenous infusion, hydration; each additional hour 1.5% 13,611 $401K
77067 Screening mammography, bilateral, including computer-aided detection 1.4% 4,047 $392K
71275 Computed tomographic angiography, chest, with contrast material 1.4% 2,105 $369K
0762 1.3% 2,920 $366K
76705 Ultrasound, abdominal, real time with image documentation; limited 1.3% 6,879 $354K
U0003 Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r 1.3% 4,870 $354K
96365 Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour 1.2% 6,602 $338K
83880 1.2% 17,144 $325K
71045 Radiologic examination, chest; single view 1.2% 22,258 $320K
71046 Radiologic examination, chest; 2 views 1.1% 15,077 $293K
99199 Unlisted special service, procedure or report 1.1% 7,814 $293K
Z7502 1.0% 7,921 $278K
99284 Emergency room visit (serious) <1% 3,600 $269K
72125 Computed tomography, cervical spine; without contrast material <1% 1,666 $262K
76856 Ultrasound, pelvic (nonobstetric), real time with image documentation; complete <1% 4,030 $241K
84484 <1% 27,936 $225K
70551 Magnetic resonance imaging, brain; without contrast material <1% 939 $206K
96360 Intravenous infusion, hydration; initial, 31 minutes to 1 hour <1% 4,702 $206K
76830 Ultrasound, transvaginal <1% 3,372 $198K
93971 <1% 2,040 $161K
83690 <1% 25,872 $155K
J2405 Injection, ondansetron hydrochloride, per 1 mg <1% 13,686 $151K
93306 Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete <1% 981 $142K
96372 Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular <1% 7,396 $138K
97140 Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) <1% 3,550 $135K
76817 Ultrasound, pregnant uterus, real time with image documentation, transvaginal <1% 2,866 $133K
J7030 Infusion, normal saline solution , 1000 cc <1% 16,892 $126K
93970 <1% 873 $125K
0260 <1% 805 $123K
78452 Myocardial perfusion imaging, tomographic (SPECT); multiple studies at rest and/or stress <1% 593 $117K
Q9967 Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml <1% 12,280 $116K
Z9725 <1% 2,635 $113K
76801 <1% 2,418 $112K
99283 Emergency room visit (moderate) <1% 2,018 $104K
76642 <1% 1,962 $103K
97110 Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion <1% 5,135 $96K
81001 <1% 31,017 $96K
0761 <1% 3,402 $95K
85730 <1% 19,037 $95K
94640 Pressurized or nonpressurized inhalation treatment for acute airway obstruction <1% 4,965 $95K
87040 <1% 8,683 $93K
87086 Culture, bacterial; quantitative colony count, urine <1% 13,255 $93K
82550 <1% 18,200 $92K
84703 <1% 11,996 $90K
G0480 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed <1% 1,762 $90K
77066 Tomosynthesis, mammo <1% 734 $83K
J0696 Injection, ceftriaxone sodium, per 250 mg <1% 7,132 $80K
85610 <1% 20,876 $75K
97139 <1% 3,515 $74K
A9500 Technetium tc-99m sestamibi, diagnostic, per study dose <1% 576 $74K
70496 <1% 306 $73K
70486 <1% 475 $70K
76815 Ultrasound, pregnant uterus, real time with image documentation, limited <1% 1,476 $67K
0160 <1% 883 $66K
J1815 Injection, insulin, per 5 units <1% 761 $64K
J1885 Injection, ketorolac tromethamine, per 15 mg <1% 11,082 $60K
87804 Infectious agent antigen detection by immunoassay; Influenza, each type <1% 8,655 $60K
70553 Magnetic resonance imaging, brain; without contrast material, followed by contrast material and further sequences <1% 140 $59K
84145 <1% 4,237 $58K
83605 <1% 4,965 $57K
77065 Tomosynthesis, mammo <1% 685 $55K
0250 <1% 23,591 $54K
J3490 Unclassified drugs <1% 14,914 $54K
82553 <1% 5,321 $50K
96366 Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour <1% 1,619 $48K
84702 <1% 3,925 $48K
U0005 Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 <1% 3,381 $47K
J2270 Injection, morphine sulfate, up to 10 mg <1% 5,979 $46K
70498 <1% 192 $46K
72100 <1% 1,590 $45K
73630 <1% 2,069 $45K
73030 <1% 1,895 $44K
96376 <1% 3,418 $43K
0202U Oncology (prostate), multianalyte, gene expression profiling <1% 206 $41K
87651 Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe <1% 1,645 $38K
73610 <1% 1,814 $38K
J2001 Injection, lidocaine hcl for intravenous infusion, 10 mg <1% 1,460 $37K
84443 Thyroid stimulating hormone (TSH) <1% 2,594 $37K
0301 <1% 920 $36K
0300 <1% 531 $36K
90715 <1% 1,096 $33K
93017 <1% 771 $32K
73562 <1% 1,641 $32K
87880 Infectious agent antigen detection by immunoassay; Streptococcus, group A <1% 3,747 $30K
77063 Screening digital breast tomosynthesis, bilateral <1% 1,098 $27K
73130 <1% 1,193 $27K
80179 <1% 1,931 $27K
93975 <1% 155 $27K
80143 <1% 1,882 $26K
87491 Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe <1% 1,796 $26K
87591 Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe <1% 1,750 $24K
J1100 Injection, dexamethasone sodium phosphate, 1 mg <1% 1,815 $24K
80048 Basic metabolic panel (calcium, ionized) <1% 2,996 $23K
A9585 Injection, gadobutrol, 0.1 ml <1% 940 $23K
81003 <1% 10,306 $22K
87186 <1% 2,446 $22K
84481 <1% 1,771 $22K
96367 <1% 734 $20K
87081 <1% 3,699 $20K
83735 <1% 3,712 $19K
81025 <1% 4,133 $18K
73110 <1% 648 $17K
0940 <1% 340 $17K
J1200 Injection, diphenhydramine hcl, up to 50 mg <1% 3,498 $17K
J2060 Injection, lorazepam, 2 mg <1% 2,935 $17K
82330 <1% 1,512 $17K
J7050 Infusion, normal saline solution, 250 cc <1% 3,286 $16K
J2785 Injection, regadenoson, 0.1 mg <1% 115 $15K
86850 <1% 2,750 $15K
73502 <1% 492 $15K
99221 <1% 588 $15K
97530 Therapeutic activities, direct patient contact, each 15 minutes <1% 898 $15K
86901 <1% 4,843 $15K
87077 <1% 2,430 $14K
87807 <1% 1,729 $14K
J2930 Injection, methylprednisolone sodium succinate, up to 125 mg <1% 1,376 $14K
84439 <1% 1,912 $14K
0710 <1% 560 $14K
J2765 Injection, metoclopramide hcl, up to 10 mg <1% 2,708 $13K
86900 <1% 4,833 $13K
86140 <1% 2,077 $13K
74018 <1% 712 $12K
99213 Doctor's office visit, returning patient (routine) <1% 436 $12K
J1170 Injection, hydromorphone, up to 4 mg <1% 1,547 $12K
71260 Computed tomography, thorax, diagnostic; with contrast material <1% 80 $12K
0258 <1% 319 $12K
85379 <1% 1,512 $11K
S0164 Injection, pantoprazole sodium, 40 mg <1% 1,214 $10K
72131 <1% 102 $10K
72148 Magnetic resonance imaging, lumbar spine; without contrast material <1% 49 $9K
0270 <1% 6,461 $9K
97750 <1% 200 $9K
72040 <1% 279 $9K
0214 <1% 13 $8K
73564 <1% 303 $7K
J7040 Infusion, normal saline solution, sterile (500 ml = 1 unit) <1% 1,180 $7K
97161 <1% 123 $7K
0636 <1% 2,002 $7K
G0378 Hospital observation service, per hour <1% 93 $7K
J1650 Injection, enoxaparin sodium, 10 mg <1% 508 $7K
0306 <1% 283 $7K
J3370 Injection, vancomycin hcl, 500 mg <1% 528 $6K
87070 <1% 758 $6K
0305 <1% 341 $6K
Z7610 <1% 966 $6K
76641 <1% 61 $6K
87205 <1% 1,473 $6K
V5008 Hearing screening <1% 289 $6K
J2704 Injection, propofol, 10 mg <1% 110 $6K
81002 <1% 2,705 $6K
80061 Lipid panel <1% 787 $5K
90471 Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine <1% 1,258 $5K
70491 <1% 37 $5K
83036 Hemoglobin; glycosylated (A1C) <1% 813 $5K
J1644 Injection, heparin sodium, per 1000 units <1% 314 $5K
36415 Collection of venous blood by venipuncture <1% 3,063 $5K
80047 <1% 797 $5K
85027 <1% 968 $4K
73140 <1% 263 $4K
84100 <1% 1,198 $4K
73080 <1% 145 $4K
97163 <1% 27 $4K
73700 <1% 12 $3K
76870 <1% 93 $3K
71020 <1% 137 $3K
76770 <1% 52 $3K
85652 <1% 787 $3K
76700 Ultrasound, abdominal, real time with image documentation; complete <1% 53 $3K
76819 Fetal biophysical profile; without non-stress testing <1% 76 $2K
0324 <1% 314 $2K
92585 <1% 55 $2K
97162 <1% 40 $2K
A4217 Sterile water/saline, 500 ml <1% 582 $2K
80076 <1% 327 $2K
J2250 Injection, midazolam hydrochloride, per 1 mg <1% 283 $2K
87210 <1% 611 $2K
71101 <1% 68 $2K
87420 <1% 524 $2K
85014 <1% 1,231 $2K
87661 Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe <1% 84 $2K
J7120 Ringers lactate infusion, up to 1000 cc <1% 376 $2K
82010 <1% 307 $2K
G0279 Diagnostic digital breast tomosynthesis, unilateral or bilateral (list separately in addition to 77065 or 77066) <1% 82 $2K
87088 <1% 447 $2K
71250 <1% 12 $2K
0370 <1% 30 $2K
73590 <1% 104 $1K
92558 <1% 53 $1K
J2919 Injection, methylprednisolone sodium succinate, 5 mg <1% 64 $1K
83930 <1% 186 $1K
G1004 Clinical decision support mechanism national decision support company, as defined by the medicare appropriate use criteria program <1% 6,072 $1K
A0429 Emergency ambulance ride, basic life support <1% 17 $1K
87426 Infectious agent antigen detection, SARS-CoV-2 (COVID-19) <1% 61 $1K
J0280 Injection, aminophyllin, up to 250 mg <1% 83 $993.06
71010 <1% 73 $960.40
86308 <1% 136 $945.84
88305 Level IV - Surgical pathology, gross and microscopic examination <1% 52 $865.05
J1630 Injection, haloperidol, up to 5 mg <1% 144 $846.76
J3010 Injection, fentanyl citrate, 0.1 mg <1% 291 $844.31
99282 Emergency department visit for the evaluation and management, low to moderate severity <1% 27 $816.22
J3475 Injection, magnesium sulfate, per 500 mg <1% 44 $756.23
82077 <1% 64 $733.60
J1836 Injection, metronidazole, 10 mg <1% 24 $730.58
J3486 Injection, ziprasidone mesylate, 10 mg <1% 33 $722.33
J3411 Injection, thiamine hcl, 100 mg <1% 63 $570.03
J1940 Injection, furosemide, up to 20 mg <1% 65 $527.17
J2272 Injection, morphine sulfate (fresenius kabi), not therapeutically equivalent to j2270, up to 10 mg <1% 65 $509.26
97802 <1% 36 $507.93
84132 <1% 106 $452.55
73560 <1% 31 $398.00
Q0162 Ondansetron 1 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen <1% 633 $387.92
J0360 Injection, hydralazine hcl, up to 20 mg <1% 56 $320.34
84550 <1% 100 $260.76
29515 <1% 31 $227.97
A4649 Surgical supply; miscellaneous <1% 1,426 $224.48
J1245 Injection, dipyridamole, per 10 mg <1% 25 $180.34
J2470 Injection, pantoprazole sodium, 40 mg <1% 76 $150.52
J0706 Injection, caffeine citrate, 5 mg <1% 13 $140.92
87045 <1% 24 $139.16
0760 <1% 26 $136.40
29125 <1% 28 $134.79
0637 <1% 449 $112.84
J7042 5% dextrose/normal saline (500 ml = 1 unit) <1% 15 $111.97
J7512 Prednisone, immediate release or delayed release, oral, 1 mg <1% 461 $101.41
J7060 5% dextrose/water (500 ml = 1 unit) <1% 17 $82.79
G8978 Mobility: walking & moving around functional limitation, current status, at therapy episode outset and at reporting intervals <1% 55 $81.25
82247 <1% 14 $33.29
J0690 Injection, cefazolin sodium, 500 mg <1% 17 $20.42
A9270 Non-covered item or service <1% 154 $16.61
J7510 Prednisolone oral, per 5 mg <1% 74 $14.01
0302 <1% 141 $1.91
99070 <1% 40 $1.83
0410 0% 14 $0.00
S9445 Patient education, not otherwise classified, non-physician provider, individual, per session 0% 111 $0.00
0307 0% 44 $0.00
G8979 Mobility: walking & moving around functional limitation, projected goal status, at therapy episode outset, at reporting intervals, and at discharge or to end reporting 0% 29 $0.00
0730 0% 39 $0.00

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.

From NPPES

Who's on the registration

Authorized officialANDERSON, DONALD (ASSISTANT SECRETARY ENROLLMENTS)
Same official

Other billing entities under ANDERSON, DONALD

Full network →

Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.